These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37773570)

  • 1. Alpha-Fetoprotein as a Factor of Differentiation and Functional Activity of Myeloid-Derived Suppressor Cells.
    Shardina KY; Zamorina SA; Timganova VP; Bochkova MS; Uzhviyuk SV; Chereshnev VA
    Bull Exp Biol Med; 2023 Aug; 175(4):535-543. PubMed ID: 37773570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Alpha-Fetoprotein on Differentiation of Myeloid Supressor Cells.
    Zamorina SA; Shardina KY; Timganova VP; Bochkova MS; Uzhviyuk SV; Raev MB; Chereshnev VA
    Dokl Biochem Biophys; 2021 Nov; 501(1):434-437. PubMed ID: 34966967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M-MDSC
    Aintablian A; Strozniak S; Heuer M; Lutz MB
    Front Immunol; 2023; 14():1130600. PubMed ID: 37275910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
    Lechner MG; Liebertz DJ; Epstein AL
    J Immunol; 2010 Aug; 185(4):2273-84. PubMed ID: 20644162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
    Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Inhibitory Molecules (Arginase-1, IDO, and PD-L1) by Myeloid-Derived Suppressor Cells in Multiple Myeloma Patients in Remission.
    Tyrinova TV; Batorov EV; Aristova TA; Ushakova GY; Sizikova SA; Denisova VV; Ostanin AA; Chernykh ER
    Bull Exp Biol Med; 2022 Nov; 174(1):71-75. PubMed ID: 36437327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia.
    Zarobkiewicz M; Kowalska W; Chocholska S; Tomczak W; Szymańska A; Morawska I; Wojciechowska A; Bojarska-Junak A
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Graphene Oxide Nanoparticles on Differentiation of Myeloid Suppressor Cells.
    Zamorina SA; Shardina KY; Timganova VP; Bochkova MS; Nechaev AI; Khramtsov PV; Raev MB
    Bull Exp Biol Med; 2020 Nov; 170(1):84-87. PubMed ID: 33222087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, development, and biological function of myeloid-derived suppressor cells.
    Zhao Y; Wu T; Shao S; Shi B; Zhao Y
    Oncoimmunology; 2016 Feb; 5(2):e1004983. PubMed ID: 27057424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
    Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
    J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells (MDSC) in Acute Myeloid Leukemia.
    Lv J; Zhao Y; Zong H; Ma G; Wei X; Zhao Y
    Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.